Tofacitinib and faecal microbiota transplantation in treating checkpoint inhibitor-induced enterocolitis: case report.

Rikke Boedker Holmstroem Emilie Kristine Dahl Morten Helms Henrik Vedel NielsenJanne Bayer AndersenJacob Tveiten Bjerrum Inge Marie Svane Eva Ellebaek Jakob Benedict Seidelin

Published in: BMJ open gastroenterology (2023)

This case supports that tofacitinib may be an(other) effective agent in managing multirefractory ICI-induced diarrhoea caused by colitis and/or enteritis.

Keyphrases

case report
rheumatoid arthritis
high glucose
diabetic rats
ulcerative colitis
dna damage
drug induced
stem cells
oxidative stress
cell cycle
cell therapy
cell proliferation
low birth weight